# Diabetes – Non-Insulin

## Length of Authorizations

365 Days

## Prior Authorization Criteria

Is there any reason the patient cannot be changed to a medication within the same class not requiring prior approval? Acceptable reasons include:

-   Allergy to medications not requiring prior approval
-   Contraindication to or drug interaction with medications not requiring prior approval
-   History of unacceptable/toxic side effects to medications not requiring prior approval

## Additional Criteria

### Non-Preferred

1.  There must have been a therapeutic failure of at least 60-day trial and failure with three preferred products

    Note: Inadequate clinical response after at least 60 days of recommended therapeutic dose with documented adherence to the regimen.

#### Diabetes - Oral Hypoglycemics, Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor And DPP-4 Combinations

| **Preferred**                                                                 | **Non-Preferred**                      |
| ----------------------------------------------------------------------------- | -------------------------------------- |
| No less than **90 days** of at least **one** preferred DPP-4 and SGLT product | GLYXAMBI (empagliflozin/ linagliptin)  |
|                                                                               | QTERN (dapaglifozin-saxagliptin)       |
|                                                                               | STEGLUJAN™ (ertugliflozin/sitagliptin) |

Soliqua and Xultophy Request must address inability to use the individual components.

## Formulary

Endocrine Agents: Diabetes – Non-Insulin

### Preferred

| Preferred                               |      |
| :-------------------------------------- | ---: |
| Acarbose                                |      |
| Actoplus Met XR                         |      |
| Byetta                                  |      |
| Farxiga                                 |      |
| Glimepiride                             |      |
| Glipizide                               |      |
| Glipizide/Metformin                     |      |
| Glyburide                               |      |
| Glyburide/Metformin                     |      |
| Invokamet                               |      |
| Invokana                                |      |
| Janumet                                 |      |
| Janumet XR                              |      |
| Januvia                                 |      |
| Jardiance                               |      |
| Jentadueto                              |      |
| Metformin                               |      |
| Metformin ER (Generic of Glucophage XR) |      |
| Miglitol                                |      |
| Nateglinide                             |      |
| Pioglitazone                            |      |
| Pioglitazone/Metformin                  |      |
| Repaglinide                             |      |
| Repaglinide/Metformin                   |      |
| Synjardy                                |      |
| Tradjenta                               |      |
| Trulicity                               |      |
| Victoza                                 |      |

### Non-Preferred

| Non-Preferred                      |      |
| :--------------------------------- | ---: |
| Adlyxin                            |      |
| Alogliptin                         |      |
| Alogliptin/Metformin               |      |
| Bydureon Bcise                     |      |
| Glimepiride/Pioglitazone           |      |
| Glucophage                         |      |
| Glyxambi                           |      |
| Invokamet XR                       |      |
| Jentadueto XR                      |      |
| Kombiglyze XR                      |      |
| Metformin ER (Generic of Fortamet) |      |
| Metformin Sol                      |      |
| Onglyza                            |      |
| Ozempic                            |      |
| Pioglitazone/Alogliptin            |      |
| Qtern                              |      |
| Rybelsus                           |      |
| Segluromet                         |      |
| Soliqua                            |      |
| Steglatro                          |      |
| Steglujan                          |      |
| Symlinpen                          |      |
| Synjardy XR                        |      |
| Trijardy XR                        |      |
| Xigduo XR                          |      |
| Xultophy                           |      |

## Links

[Criteria](https://pharmacy.medicaid.ohio.gov/sites/default/files/20221001_UPDL_Criteria_APPROVED.pdf#page=51)

[Preferred Drug List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20221001_UPDL_APPROVED_.pdf#page=20)